Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$552.39 USD

552.39
876,845

-11.61 (-2.06%)

Updated May 21, 2024 04:00 PM ET

After-Market: $553.10 +0.71 (0.13%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (164 out of 248)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Should You Buy McKesson Corporation (MCK) Ahead of Earnings?

McKesson (MCK) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

    Mckesson (MCK) to Report Q2 Earnings: A Beat in the Cards?

    McKesson Corporation (MCK) expects a strong second quarter owing to a gradually stabilizing generic and branded market.

      Is McKesson (MCK) a Great Stock for Value Investors?

      Let's see if McKesson Corporation (MCK) stock is a good choice for value-oriented investors right now from multiple angles.

        AmerisourceBergen's PharMEDium Slows Down, Competition Rife

        AmerisourceBergen Corporation (ABC) is facing immediate integration risks from its acquisition of PharMEDium. Also, competition in the generic space raise concern.

          McKesson (MCK) Misses on Earnings and Sales in Q1

          McKesson???s adjusted earnings of $2.46 per share missed the Zacks Consensus Estimate of $2.81 and decreased from $3.15 in the year-ago quarter.

            AmerisourceBergen's PharMEDium Slows Down, Competition Rife

            On Jul 10, we issued an updated research report on Chesterbrook, PA-based AmerisourceBergen Corporation (ABC).

              Should Value Investors Consider McKesson (MCK) Stock?

              Value investing is easily one of the most popular ways to find great stocks in any market environment.

                Why Is McKesson (MCK) Up 13% Since the Last Earnings Report?

                McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                  McKesson (MCK) Up 7.5% Since Earnings Report: Can It Continue?

                  McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                    McKesson Corporation: Should Value Investors Pick this Stock?

                    Value investing is easily one of the most popular ways to find great stocks in any market environment.

                      McKesson (MCK) Beats on Earnings in Q3, Inks Buyout Deal

                      McKesson Corporation (MCK) reported third-quarter fiscal 2017 earnings of $3.03 per share, beating the Zacks Consensus Estimate of $2.95 but declining from the year-ago figure of $3.18.

                        McKesson (MCK) Q3 Earnings: Stock Likely to Disappoint?

                        McKesson Corporation (MCK), one of the largest healthcare services providers, is scheduled to report third-quarter fiscal 2017 results on Jan 25.

                          McKesson (MCK) to Pay $150 Million to Department of Justice

                          McKesson (MCK) has finalized to resolve U.S. Drug Enforcement Administration and Department of Justice potential federal civil and administrative claims.

                            McKesson (MCK) Closes Rexall Health Acquisition in Canada

                            McKesson Corporation (MCK) announced that it has completed the acquisition of Canada-based Rexall Health for $2.1 billion

                              Sheraz Mian headshot

                              A Whole Lot of Nothing

                              Stocks haven't done much lately and the trend will likely continue for some time.

                                Sheraz Mian headshot

                                Top Research Reports for Morgan Stanely, Union Pacific & AbbVie

                                Today's must-read reports are for AbbVie (ABBV), Morgan Stanley (MS) and Union Pacific (UNP).

                                  Sheraz Mian headshot

                                  Where Do We Go From Here?

                                  The post-Brexit rally has taken many by surprise, but it does beg the question of where we go from here.

                                    Sheraz Mian headshot

                                    Top 6 Research Reports for July 7, 2016

                                    Today's must-read reports are for Expedia (EXPE), BP (BP) and McKesson (MCK).

                                      Sheraz Mian headshot

                                      Top 6 Research Reports for June 30, 2016

                                      Today's must-read reports are for Alphabet (GOOGL), Monsanto (MON) and McKesson (MCK).

                                        Top 3 MedTech Stocks Poised to Gain this Earnings Season

                                        A bipartisan group of ten senators signed on a bill to repeal the 2.3% federal excise tax on medical device makers.